Fifth Avenue Eye Associates   Report issue

Academic/Hospital Phase 3
Founded: New York NY United States (1973)

Organization Overview

First Clinical Trial
2020
NCT04249076
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Director of refractive surgery and laser vision correction at 5th Avenue Eye Associates

Active Ingredients

Drugs in Phase 3 Trials (1)

clobetasol (dermovate) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cataract (Phase 3)

Inflammation (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1